These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 8666327)

  • 21. Effects of hydrophobic and hydrophilic bile salts on gallstone growth and dissolution in model biles.
    Venneman NG; van Kammen M; Renooij W; Vanberge-Henegouwen GP; van Erpecum KJ
    Biochim Biophys Acta; 2005 Jan; 1686(3):209-19. PubMed ID: 15629690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesterol crystals and the formation of cholesterol gallstones.
    Sedaghat A; Grundy SM
    N Engl J Med; 1980 Jun; 302(23):1274-7. PubMed ID: 7366692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of bile and gallstones in 116 patients with symptomatic cholelithiasis].
    van Erpecum KJ; van Berge Henegouwen GP; Stoelwinder B; Stolk MF; Eggink WF; Govaert WH
    Ned Tijdschr Geneeskd; 1990 Jan; 134(3):116-20. PubMed ID: 2300226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in gallbladder bile composition and crystal detection time in morbidly obese subjects after bariatric surgery.
    Gustafsson U; Benthin L; Granström L; Groen AK; Sahlin S; Einarsson C
    Hepatology; 2005 Jun; 41(6):1322-8. PubMed ID: 15834935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Free fatty acids in gallbladder bile].
    Wang W; Han T; Zhang S
    Zhonghua Wai Ke Za Zhi; 1995 Nov; 33(11):659-61. PubMed ID: 8731909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routine determination of biliary lipid composition with the entero-test.
    Muraca M; Pazzi P; Vilei MT; Miconi L; Granato A; Cianci V; Sighinolfi D; Alvisi A; Gerunda G; Maffei Faccioli A
    Ann Chir; 1994; 48(2):197-200. PubMed ID: 8192414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phospholipid molecular species influence crystal habits and transition sequences of metastable intermediates during cholesterol crystallization from bile salt-rich model bile.
    Konikoff FM; Cohen DE; Carey MC
    J Lipid Res; 1994 Jan; 35(1):60-70. PubMed ID: 8138723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.
    Broomfield PH; Chopra R; Sheinbaum RC; Bonorris GG; Silverman A; Schoenfield LJ; Marks JW
    N Engl J Med; 1988 Dec; 319(24):1567-72. PubMed ID: 3200265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of crystallization pathways during cholesterol precipitation from human gallbladder biles: identical pathways to corresponding model biles with three predominating sequences.
    Wang DQ; Carey MC
    J Lipid Res; 1996 Dec; 37(12):2539-49. PubMed ID: 9017506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical epidemiology of gallbladder cancer.
    Strom BL; Soloway RD; Rios-Dalenz J; Rodriguez-Martinez HA; West SL; Kinman JL; Crowther RS; Taylor D; Polansky M; Berlin JA
    Hepatology; 1996 Jun; 23(6):1402-11. PubMed ID: 8675157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bile concentration is a key factor for nucleation of cholesterol crystals and cholesterol saturation index in gallbladder bile of gallstone patients.
    van Erpecum KJ; van Berge Henegouwen GP; Stoelwinder B; Schmidt YM; Willekens FL
    Hepatology; 1990 Jan; 11(1):1-6. PubMed ID: 2295460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
    Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
    Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arachidyl amido cholanoic acid (Aramchol) is a cholesterol solubilizer and prevents the formation of cholesterol gallstones in inbred mice.
    Gilat T; Leikin-Frenkel A; Goldiner L; Laufer H; Halpern Z; Konikoff FM
    Lipids; 2001 Oct; 36(10):1135-40. PubMed ID: 11768158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of cholesterol-carrying particles in human gallbladder bile.
    Eckhardt ER; van de Heijning BJ; van Erpecum KJ; Renooij W; VanBerge-Henegouwen GP
    J Lipid Res; 1998 Mar; 39(3):594-603. PubMed ID: 9548591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittency of cholesterol crystals in duodenal bile from gallstone patients.
    Marks JW; Bonorris G
    Gastroenterology; 1984 Sep; 87(3):622-7. PubMed ID: 6745615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete mapping of crystallization pathways during cholesterol precipitation from model bile: influence of physical-chemical variables of pathophysiologic relevance and identification of a stable liquid crystalline state in cold, dilute and hydrophilic bile salt-containing systems.
    Wang DQ; Carey MC
    J Lipid Res; 1996 Mar; 37(3):606-30. PubMed ID: 8728323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microstructural evolution of lipid aggregates in nucleating model and human biles visualized by cryogenic transmission electron microscopy.
    Konikoff FM; Danino D; Weihs D; Rubin M; Talmon Y
    Hepatology; 2000 Feb; 31(2):261-8. PubMed ID: 10655245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of a quantitative assay for cholesterol crystal growth in human gallbladder bile.
    Ginanni Corradini S; Cantafora A; Capocaccia L; Della Guardia P; Giacomelli L; Angelico M
    Biochim Biophys Acta; 1994 Aug; 1214(1):63-72. PubMed ID: 8068730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nucleation time and lithogenic index in obese patients and in patients with cholecystolithiasis].
    Janowitz P; Wechsler JG; Swobodnik W; Fischer S; Förstner J; Ditschuneit H
    Z Gastroenterol; 1988 Dec; 26(12):750-4. PubMed ID: 3245253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.